Literature DB >> 35693410

Patient with unresectable colorectal liver metastases and asymptomatic primary tumor: end of the debate!

Marc-Antoine Allard1,2, René Adam1,2.   

Abstract

Entities:  

Year:  2022        PMID： 35693410      PMCID： PMC9186187          DOI： 10.21037/hbsn-22-176

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   8.265


× No keyword cloud information.
  9 in total

1.  Association between palliative resection of the primary tumor and overall survival in a population-based cohort of metastatic colorectal cancer patients.

Authors:  Gillian Gresham; Daniel J Renouf; Matthew Chan; Hagen F Kennecke; Howard J Lim; Carl Brown; Winson Y Cheung
Journal:  Ann Surg Oncol       Date:  2014-05-24       Impact factor: 5.344

2.  Prognostic impact of primary tumor resection and lymph node dissection in stage IV colorectal cancer with unresectable metastasis: a propensity score analysis in a multicenter retrospective study.

Authors:  Soichiro Ishihara; Tamuro Hayama; Hideki Yamada; Keijiro Nozawa; Keiji Matsuda; Hiroaki Miyata; Satomi Yoneyama; Toshiaki Tanaka; Junichiro Tanaka; Tomomichi Kiyomatsu; Kazushige Kawai; Hioaki Nozawa; Takamitsu Kanazawa; Shinsuke Kazama; Hironori Yamaguchi; Eiji Sunami; Joji Kitayama; Yojiro Hashiguchi; Kenichi Sugihara; Toshiaki Watanabe
Journal:  Ann Surg Oncol       Date:  2014-04-24       Impact factor: 5.344

3.  Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials.

Authors:  Matthieu Faron; Jean-Pierre Pignon; David Malka; Abderrahmane Bourredjem; Jean-Yves Douillard; Antoine Adenis; Dominique Elias; Olivier Bouché; Michel Ducreux
Journal:  Eur J Cancer       Date:  2014-11-24       Impact factor: 9.162

4.  Sixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment: The CAIRO4 Phase 3 Randomized Clinical Trial.

Authors:  Dave E W van der Kruijssen; Sjoerd G Elias; Geraldine R Vink; Karlijn L van Rooijen; Jorine 't Lam-Boer; Linda Mol; Cornelis J A Punt; Johannes H W de Wilt; Miriam Koopman
Journal:  JAMA Surg       Date:  2021-12-01       Impact factor: 16.681

5.  First-line chemotherapy vs bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases.

Authors:  Gennaro Galizia; Eva Lieto; Michele Orditura; Paolo Castellano; Vincenzo Imperatore; Margherita Pinto; Anna Zamboli
Journal:  Arch Surg       Date:  2008-04

6.  Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601.

Authors:  F Ferrand; D Malka; A Bourredjem; C Allonier; O Bouché; S Louafi; V Boige; M Mousseau; J L Raoul; L Bedenne; B Leduc; P Deguiral; M Faron; J P Pignon; M Ducreux
Journal:  Eur J Cancer       Date:  2012-08-25       Impact factor: 9.162

7.  Survival impact of surgical resection of primary tumor in patients with stage IV colorectal cancer: results from a large population-based cohort study.

Authors:  Shahid Ahmed; Anne Leis; Anthony Fields; Selliah Chandra-Kanthan; Kamal Haider; Riaz Alvi; Bruce Reeder; Punam Pahwa
Journal:  Cancer       Date:  2013-11-12       Impact factor: 6.860

8.  Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS--a randomised controlled multicentre trial (ISRCTN30964555).

Authors:  Nuh N Rahbari; Florian Lordick; Christine Fink; Ulrich Bork; Annika Stange; Dirk Jäger; Steffen P Luntz; Stefan Englert; Inga Rossion; Moritz Koch; Markus W Büchler; Meinhard Kieser; Jürgen Weitz
Journal:  BMC Cancer       Date:  2012-04-05       Impact factor: 4.430

9.  Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial.

Authors:  Yukihide Kanemitsu; Kohei Shitara; Junki Mizusawa; Tetsuya Hamaguchi; Dai Shida; Koji Komori; Satoshi Ikeda; Hitoshi Ojima; Hideyuki Ike; Akio Shiomi; Jun Watanabe; Yasumasa Takii; Takashi Yamaguchi; Kenji Katsumata; Masaaki Ito; Junji Okuda; Ryoji Hyakudomi; Yasuhiro Shimada; Hiroshi Katayama; Haruhiko Fukuda
Journal:  J Clin Oncol       Date:  2021-02-09       Impact factor: 44.544
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.